Bottom-up assembly of RNA nanoparticles containing phi29 motor pRNA to silence the asthma STAT5b gene

Genetics and Molecular Research

Volumn 11, Issue 3, 2012, Pages 3236-3245

  Qiu, C ^a   Peng, W K ^a   Shi, F ^a   Zhang, T ^a  

^a SHENZHEN PEOPLE'S HOSPITAL   (China)

Author keywords

Aptamer; Asthma; Nanotechnology; PRNA; SiRNA; STAT5b

Indexed keywords

APTAMER; CD4 ANTIGEN; MESSENGER RNA; NANOCARRIER; PACKAGING RNA; SMALL INTERFERING RNA; STAT5B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BACTERIOPHAGE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOLECULAR RECOGNITION; MOUSE; NANOFABRICATION; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 5B GENE; SPLEEN LYMPHOCYTE; TARGET CELL;

ANIMALS; ASTHMA; BACILLUS PHAGES; BASE SEQUENCE; CELL DEATH; DIMERIZATION; FEMALE; GENE SILENCING; LUNG; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NANOPARTICLES; NUCLEIC ACID CONFORMATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; RNA, VIRAL; SINCALIDE; STAT5 TRANSCRIPTION FACTOR; VIRUS ASSEMBLY;

EID: 84930481301     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2012.September.12.6     Document Type: Article

References (18)

1. Castanotto D and Rossi JJ (2009). The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433.
2. Chen C, Sheng S, Shao Z and Guo P (2000). A dimer as a building block in assembling RNA. A hexamer that gears bacterial virus phi29 DNA-translocating machinery. J. Biol. Chem. 275: 17510-17516.
3. Dorsett Y and Tuschl T (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug. Discov. 3: 318-329.
4. Elbashir SM, Lendeckel W and Tuschl T (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15: 188-200.
5. Guo P (2010). The emerging feld of RNA nanotechnology. Nat. Nanotechnol. 5: 833-842.
6. Guo S, Tschammer N, Mohammed S and Guo P (2005). Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA. Hum. Gene Ther. 16: 1097-1109.
7. Kraus E, James W and Barclay AN (1998). Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. J. Immunol. 160: 5209-5212.
8. Lee TJ, Schwartz C and Guo P (2009). Construction of bacteriophage phi29 DNA packaging motor and its applications in nanotechnology and therapy. Ann. Biomed. Eng. 37: 2064-2081.
9. Maes T, Tournoy KG and Joos GF (2011). Gene therapy for allergic airway diseases. Curr. Allergy Asthma Rep. 11:163-172.
10. North ML, Khanna N, Marsden PA, Grasemann H, et al. (2009). Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am. J. Physiol. Lung Cell Mol. Physiol. 296: L911-L920.
11. Shu D, Huang LP, Hoeprich S and Guo P (2003). Construction of phi29 DNA-packaging RNA monomers, dimers, and trimers with variable sizes and shapes as potential parts for nanodevices. J. Nanosci. Nanotechnol. 3: 295-302.
12. Shu D, Moll WD, Deng Z, Mao C, et al. (2004). Bottom-up Assembly of RNA Arrays and Superstructures as Potential Parts in Nanotechnology. Nano Lett. 4: 1717-1723.
13. Shu Y, Shu D, Diao Z, Shen G, et al. (2009). Fabrication of Polyvalent Therapeutic RNA Nanoparticles for Specific Delivery of siRNA, Ribozyme and Drugs to Targeted Cells for Cancer Therapy. IEEE NIH Life Sci. Syst. Appl.Workshop 2009: 9-12.
14. Tarapore P, Shu Y, Guo P and Ho SM (2011). Application of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancers. Mol. Ther. 19: 386-394.
15. Zhang HM, Su Y, Guo S, Yuan J, et al. (2009). Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs. Antiviral Res. 83: 307-316.
16. Zhou J, Shu Y, Guo P, Smith DD, et al. (2011). Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. Methods 54: 284-294.
17. Zhu J (2010). Transcriptional regulation of Th2 cell differentiation. Immunol. Cell Biol. 88: 244-249.
18. Zhu J, Cote-Sierra J, Guo L and Paul WE (2003). Stat5 activation plays a critical role in Th2 differentiation. Immunity 19: 739-748.